Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CL

Insights into Colgate-Palmolive's Current Standing on Wall Street

Shares of Colgate-Palmolive have moved -1.5% today, and are now trading at a price of $77.96. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 3,578,926 compared to the stock's average volume of 5,150,857.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. Based in New York, United States the company has 34,000 full time employees and a market cap of $63,008,890,880. Colgate-Palmolive currently offers its equity investors a dividend that yields 2.6% per year.

The company is now trading -15.41% away from its average analyst target price of $92.16 per share. The 19 analysts following the stock have set target prices ranging from $82.0 to $105.0, and on average give Colgate-Palmolive a rating of buy.

Over the last 12 months CL shares have declined by -21.7%, which represents a difference of -37.6% when compared to the S&P 500. The stock's 52 week high is $102.61 per share and its 52 week low is $77.09. With its net margins declining an average -0.7% over the last 6 years, Colgate-Palmolive declining profitability gives us reason to believe its stock price will continue to underwhelm.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 20,101,000 2,889,000 14 16.67
2023 19,457,000 2,300,000 12 20.0
2022 17,967,000 1,785,000 10 -16.67
2021 17,421,000 2,166,000 12 -25.0
2020 16,471,000 2,695,000 16 6.67
2019 15,693,000 2,367,000 15
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS